1. Forum of International Respiratory Societies. The global impact of respiratory disease-second edition. European Respiratory Society: Sheffield; 2017. https://www.chestnet.org/News/Press-Releases/2017/05/FIRS-releases-The-Global-Impact-of-Respiratory-Disease-Second-Edition
2. Ferkol T, Schraufnagel D. The global burden of respiratory disease. Ann Am Thorac Soc. 2014;11(3):404–6.
3. GBD. Chronic Respiratory Disease Collaborators. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015 (2017). Lancet Respir Med. 2015;5(9):691–706.
4. Lee WH, Loo CY, Ghadiri M, Leong CR, Young PM, Traini D. The potential to treat lung cancer via inhalation of repurposed drugs. Adv Drug Deliv Rev. 2018;133:107–30.
5. Mehta P, Bothiraja C, Mahadik K, Kadam S, Pawar A. Phytoconstituent based dry powder inhalers as biomedicine for the management of pulmonary diseases. Biomed Pharmacother. 2018;108:828–37.